Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

TIDES USA: Oligonucleotide & Peptide Therapeutics
April 26-29, 2027
Hynes Convention CenterBoston, MA
Menu

Telmo Graça, PhD
Process and Technology Lead – Specialized Modalities at Lonza
Speaker

Profile

Telmo is Process and Technology Lead for mRNA at Lonza and a key member of the External Innovations team within Cell and Gene Therapies. He leads mRNA process and technology programs that transition capabilities from R&D into GMP and QC, while aligning R&D, operations, innovation, and commercial stakeholders to drive governed execution. His role includes shaping strategic, research, and licensing collaborations and advising the Global Strategy Group on technology, innovation, and investment decisions. Previously, Telmo led automated mRNA manufacturing platforms at CureVac SE. He holds a Master’s in Biological Engineering and a PhD in Immunology and Infectious Diseases.

Agenda Sessions

  • Advancing RNA Therapeutics through Process Innovation: mRNA and LNP Technologies Shaping the Future of in vivo CAR T Therapies

    , 4:45pm
    View Session

At this event

Prev
Next
Adam Oxley, PhD
Deputy Vice President of Membranes and Purification
Exactmer

See Telmo at TIDES USA: Oligonucleotide & Peptide Therapeutics